| Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 |
|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||||
Net Income | ||||||||
20,513 | 25,452 | 23,678 | 18,795 | 15,430 | 13,396 | 10,256 | 6,875 | 3,309 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | ||||||||
- | - | - | - | - | - | - | 2,230 | 2,073 |
Depreciation and amortization | ||||||||
3,836 | 3,899 | 3,533 | 3,297 | 3,544 | 3,817 | 2,421 | - | - |
Abandoned patents or software written off | ||||||||
- | - | - | 88 | 413 | 250 | 66 | 76 | 79 |
Provision (Recovery) for bad debts | ||||||||
-978 | -614 | 477 | -201 | 2,475 | 1,806 | 1,544 | - | - |
Deferred income tax - net | ||||||||
1,755 | -4,919 | -4,969 | -4,647 | -2,756 | -2,682 | -2,473 | 0 | - |
Income tax receivable | ||||||||
- | -1,200 | - | - | - | - | - | - | - |
Compensatory element of stock issuances | ||||||||
- | - | 2,397 | - | - | - | - | - | - |
Gain on Sale of Equipment | ||||||||
- | - | - | - | - | - | -557 | 0 | - |
Loss on disposition of equipment | ||||||||
- | - | - | - | - | 657 | 0 | - | - |
Gain on acquisition | ||||||||
- | - | - | -192 | - | 0 | - | - | - |
Gain on litigation settlement | ||||||||
- | - | - | - | - | - | -755 | - | - |
Impairment on management agreement | ||||||||
- | - | - | - | - | - | 357 | - | - |
Provision for bad debts | ||||||||
- | - | - | - | - | - | - | 1,050 | 963 |
Gain on litigation settlement | ||||||||
- | - | - | - | - | - | - | 0 | - |
Impairment on management agreement | ||||||||
- | - | - | - | - | - | - | 0 | - |
Compensatory element of stock issuances | ||||||||
- | - | - | 2 | 53 | 223 | 415 | 180 | - |
Gain on extinguishment of debt | ||||||||
- | - | - | - | -394 | 0 | 0 | - | - |
Issuance of common stock (value) | ||||||||
1,954 | - | 2,239 | - | 109 | 531 | 0 | - | - |
Stock option exercised | ||||||||
- | - | 1 | 1 | - | 30 | 0 | - | - |
Stock issued for costs and expenses | ||||||||
- | - | - | - | - | - | - | 427 | 862 |
Compensatory element of stock issuances | ||||||||
- | - | - | - | - | - | - | - | 204 |
(Increase) decrease in operating assets, net: | ||||||||
Accounts, medical and management fee receivable(s) | ||||||||
-6,134 | -4,328 | -5,899 | -3,557 | -4,258 | -4,044 | -3,717 | -996 | -1,550 |
Notes receivable | ||||||||
-12 | -894 | 11 | 28 | 135 | 95 | 120 | 80 | -336 |
Costs and estimated earnings in excess of billings on uncompleted contracts | ||||||||
-438 | 649 | -736 | 681 | 78 | -314 | 682 | -959 | 107 |
Inventories | ||||||||
-366 | 192 | 450 | 117 | 251 | -366 | 117 | 205 | 425 |
Prepaid expenses and other current assets | ||||||||
-79 | -1 | -513 | 72 | 67 | 46 | -698 | 174 | 200 |
Other assets | ||||||||
0 | 15 | 254 | 18 | 41 | 131 | -204 | 108 | -57 |
Increase (decrease) in operating liabilities, net: | ||||||||
Advances and notes to related medical practices | ||||||||
- | - | - | - | - | - | - | - | 83 |
Accounts payable | ||||||||
560 | -122 | 168 | -527 | -699 | -270 | 628 | -164 | -1,012 |
Other current liabilities | ||||||||
-980 | 525 | -3,660 | 3,065 | -1,041 | 295 | -414 | -830 | 699 |
Customer deposits | ||||||||
-59 | 70 | -410 | -739 | 11 | 68 | -567 | -964 | 32 |
Billings in excess of costs and estimated earnings on uncompleted contracts | ||||||||
- | - | -206 | 64 | - | 0 | 142 | - | - |
Billings in excess of costs and estimated earnings on uncompleted contracts | ||||||||
-438 | 649 | -736 | 681 | 78 | -314 | 682 | -959 | 107 |
Billings in excess of costs and estimated earnings on uncompleted contracts | ||||||||
- | - | - | - | - | - | - | -4 | -2,739 |
Other liabilities | ||||||||
- | - | - | - | - | - | - | -101 | 27 |
Other Liabilities | ||||||||
11 | 16 | 8 | 242 | -190 | -268 | 253 | - | - |
Due to related party medical practices | ||||||||
-134 | - | -17 | 8 | 2 | 3 | 1 | 0 | -299 |
Income tax payable | ||||||||
- | - | - | - | - | -19 | -80 | 25 | 75 |
Net cash provided by operating activities | ||||||||
19,448 | 18,739 | 16,807 | 16,617 | 13,272 | 13,390 | 7,539 | 7,413 | 3,148 |
Cash Flows from Investing Activities: | ||||||||
Sales of marketable securities | ||||||||
- | - | - | - | - | - | - | - | 2 |
Purchases of property and equipment | ||||||||
-3,355 | -2,777 | -2,851 | -712 | -131 | -620 | -1,135 | 1,081 | 532 |
Short term investment | ||||||||
-15,094 | - | - | - | - | - | - | - | - |
Cost of acquisition | ||||||||
- | -58 | -1,312 | -4,223 | - | 0 | -40,000 | 0 | - |
Costs of capitalized software development | ||||||||
- | - | - | - | - | - | - | - | 67 |
Cash acquired from business combination | ||||||||
- | - | - | - | - | - | - | - | 290 |
Cost of patents | ||||||||
-128 | -108 | -155 | -113 | -139 | -214 | -159 | 146 | 135 |
Net cash used in investing activities | ||||||||
-18,578 | -2,945 | -4,319 | -5,048 | -270 | -834 | -41,295 | -1,227 | -447 |
Cash Flows from Financing Activities: | ||||||||
Proceeds from debt | ||||||||
- | - | - | - | - | - | 14,689 | - | - |
Proceeds from debt | ||||||||
- | - | - | - | - | - | - | 246 | 0 |
Proceeds from sale of equipment | ||||||||
- | - | - | - | - | - | 700 | 0 | - |
Proceeds from noncontrolling interests | ||||||||
- | - | - | - | - | - | 19,800 | 16 | 6,700 |
Repayment of borrowings and capital lease obligations | ||||||||
-30 | -172 | -3,990 | -3,682 | -2,788 | -4,400 | -1,821 | 1,387 | 1,492 |
Repayment of notes receivable from employee stockholders | ||||||||
9 | 7 | 7 | 7 | 7 | 15 | 15 | -44 | -75 |
Distributions - noncontrolling | ||||||||
-6,600 | -6,135 | -6,981 | -5,909 | -4,627 | -4,965 | -1,799 | 1,135 | 22 |
Redemption of noncontroling Interests | ||||||||
- | - | - | -2,905 | -1,125 | -1,125 | -1,424 | -1,200 | - |
Proceeds received from acquisition -net | ||||||||
- | - | 87 | - | - | - | - | - | - |
Redemption of Non-Controling Interests | ||||||||
- | - | - | -2,905 | -1,125 | - | - | -1,200 | - |
Buyout of noncontroling Interest | ||||||||
- | - | - | - | -4,971 | 0 | -564 | 0 | 10 |
Sale to non controlling interest | ||||||||
- | - | - | - | - | - | - | 10 | - |
Net cash used in financing activities | ||||||||
-6,621 | -6,300 | -10,876 | -12,489 | -13,505 | -10,475 | 29,594 | -3,405 | 5,250 |
Net Increase (decrease) in Cash and Cash Equivalents | ||||||||
-5,751 | 9,494 | 1,611 | -920 | -502 | 2,081 | -4,161 | 2,780 | 7,951 |